Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) Shares Outstanding (Diluted Average) (2018 - 2022)

Bioceres Crop Solutions' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $42.3 million for Q2 2022.

  • For Q2 2022, Shares Outstanding (Diluted Average) rose 7.86% year-over-year to $42.3 million; the TTM value through Jun 2022 reached $42.3 million, up 7.86%, while the annual FY2022 figure was $42.3 million, 7.86% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q2 2022 was $42.3 million at Bioceres Crop Solutions, up from $39.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $42.3 million in Q2 2022 and bottomed at $28.1 million in Q2 2018.
  • The 5-year median for Shares Outstanding (Diluted Average) is $36.4 million (2020), against an average of $35.3 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) increased 19.48% in 2020 before it increased 7.69% in 2021.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $28.1 million in 2018, then rose by 8.47% to $30.5 million in 2019, then rose by 19.48% to $36.4 million in 2020, then increased by 7.69% to $39.2 million in 2021, then rose by 7.86% to $42.3 million in 2022.
  • Per Business Quant, the three most recent readings for BIOX's Shares Outstanding (Diluted Average) are $42.3 million (Q2 2022), $39.2 million (Q2 2021), and $36.4 million (Q2 2020).